Biotech

Health Canada Clears Immunovaccine for Ovarian Cancer Vaccine Trials

HALIFAX, NOVA SCOTIA: ...

AVI BioPharma Announces Third Quarter 2011 Financial Results and Corporate Update Conference Call

BOTHELL, WA: ...

Octapharma Locks-in Binding Forecast to Exceed $2M for ProMetic's Prion Capture Resin for H1 2012

LAVAL, QUEBEC, CANADA AND CAMBRIDGE, UNITED KINGDOM: -Binding forecast in excess of $2 Million for the first 6 month of 2012 -New forecast incremental to $0.73 Million order announced earlier this month ...

Titan Pharmaceuticals Provides Probuphine Update After Meeting With U.S. Food and Drug Administration

SOUTH SAN FRANCISCO, CA: Regulatory Path Defined for New Drug Application ...

Pacgen Appoints Dr. Ming S. Liu as CEO

VANCOUVER, BRITISH COLUMBIA: ...

Cellceutix to File Investigational New Drug Application for Novel p53 Anti-Cancer Drug

BEVERLY, MA: Cellceutix Completes Clinical Protocol With Hosting Hospital; Receives Signed Forms Needed for Filing Investigational New Drug Application ...

Allon's CEO Presenting at BIO Investor Forum

VANCOUVER, BRITISH COLUMBIA: ...

Del Mar Pharmaceuticals Initiates Glioblastoma Clinical Trial

VANCOUVER, BRITISH COLUMBIA: ...

Thallion Pharmaceuticals Inc.: Blinded Results From Low Dose Cohort of Phase II SHIGATEC Trial Presented at IDSA Annual Meeting

MONTREAL, QUEBEC: ...

PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials

OTTAWA, ONTARIO: ...